In Vitro Activity of Trovafloxacin against Bacteroides fragilis in Mixed Culture with either Escherichia coli or a Vancomycin- Resistant Strain of Enterococcus faecium Determined by an Anaerobic Time-Kill Technique

Author:

Stearne Lorna E. T.1,Kooi Clarissa1,Goessens Wil H. F.1,Bakker-Woudenberg Irma A. J. M.1,Gyssens Inge C.1

Affiliation:

1. Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, The Netherlands

Abstract

ABSTRACT To determine the efficacy of trovafloxacin as a possible treatment for intra-abdominal abscesses, we have developed an anaerobic time-kill technique using different inocula to study the in vitro killing of Bacteroides fragilis in pure culture or in mixed culture with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium (VREF). With inocula of 5 × 10 5 CFU/ml and trovafloxacin concentrations of ≤2 μg/ml, a maximum observed effect ( E max ) of ≥6.1 (log 10 CFU/ml) was attained with all pure and mixed cultures within 24 h. With inocula of 10 8 CFU/ml, a similar E max and a similar concentration to produce 50% of E max (EC 50 ) for B. fragilis were found in both pure cultures and mixed cultures with E. coli . However, to produce a similar killing of B. fragilis in the mixed cultures with VREF, a 14-fold increase in the concentration of trovafloxacin was required. A vancomycin-susceptible strain of E. faecium and a trovafloxacin-resistant strain of E. coli were also found to confer a similar “protective” effect on B. fragilis against the activity of trovafloxacin. Using inocula of 10 9 CFU/ml, the activity of trovafloxacin was retained for E. coli and B. fragilis and was negligible against VREF. We conclude that this is a useful technique to study the anaerobic killing of mixed cultures in vitro and may be of value in predicting the killing of mixed infections in vivo. The importance of using mixed cultures and not pure cultures is clearly shown by the difference in the killing of B. fragilis in the mixed cultures tested. Trovafloxacin will probably be ineffective in the treatment of infections involving large numbers of enterococci. However, due to its ability to retain activity against large cultures of B. fragilis and E. coli , trovafloxacin could be beneficial in the treatment of intra-abdominal abscesses.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Reference32 articles.

1. Comparative in vitro activities of trovafloxacin (CP 99,219) and other antimicrobials against clinically significant anaerobes

2. Amsterdam D. Susceptibility testing of antimicrobials in liquid media Antibiotics in laboratory medicine 3rd ed. Lorian V. 1991 53 105 Williams & Wilkens Co. Baltimore Md

3. The chemistry and biological profile of trovafloxacin.;Bightly K. E.;J. Antimicrob. Chemother.,1997

4. In vitro susceptibility vs in vivo efficacy of various antimicrobial agents against the Bacteroides fragilis group.;Brook I.;Rev. Infect. Dis.,1991

5. Inoculum effect.;Brook I.;Rev. Infect. Dis.,1989

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3